Responsiveness of T Cells to Interleukin-7 Is Associated with Higher CD4+ T Cell Counts in HIV-1-Positive Individuals with Highly Active Antiretroviral Therapy-Induced Viral Load Suppression

Camargo, Jose F.; Kulkarni, Hemant; Agan, Brian K.; Gaitan, Alvaro A.; Beachy, Lisa A.; Srinivas, Sowmya; Weijing He; Anderson, Stephanie; Marconi, Vincent C.; Dolan, Matthew J.; Ahuja, Sunil K.
June 2009
Journal of Infectious Diseases;6/15/2009, Vol. 199 Issue 12, p1872
Academic Journal
Background. Despite suppression of the human immunodeficiency virus type1 (HIV-1)load by highly active antiretroviral therapy (HAART), recovery of CD4+ Tcell counts can be impaired. We investigated whether this impairment may be associated with hyporesponsiveness of T cells to γ-chain (γc) cytokines known to influence T cell homeostasis. Methods. The responsiveness of T cells to interleukin (IL)-2, IL-7, and IL-15 was determined by assessing cytokine-induced phosphorylation of the signal transducer and activator of transcription 5 (STAT5) in peripheral T cells obtained from 118 HIV-positive subjects and 13 HIV-negative subjects. Results. The responsiveness of T cells to interleukin (IL)-7 but not to IL-2 or IL-15 was lower among HIV-positive subjects than among HIV-negative subjects. Among subjects with viral load suppression, the degree of IL-7 responsiveness (1) correlated with naive CD4+ T cell counts and was a better immune correlate of the prevailing CD4+ T cell count than were levels of human leukocyte antigen-DR1 or programmed death-1, which are predictors of T cell homeostasis during HIV infection; and (2) was greater in subjects with complete (i.e., attainment of ⩾500 CD4+ T cells/mm³ ⩾5 years after initiation of HAART) versus incomplete immunologic responses. The correlation between plasma levels of IL-7 and CD4+ T cell counts during HAART was maximal in subjects with increased IL-7 responsiveness. Conclusions. Responsiveness of T cells to IL-7 is associated with higher CD4+ T cell counts during HAART and thus may be a determinant of the extent of immune reconstitution.


Related Articles

  • Engineering T Cells to Functionally Cure HIV-1 Infection. Leibman, Rachel S; Riley, James L // Molecular Therapy;Jul2015, Vol. 23 Issue 7, p1149 

    Despite the ability of antiretroviral therapy to minimize human immunodeficiency virus type 1 (HIV-1) replication and increase the duration and quality of patients' lives, the health consequences and financial burden associated with the lifelong treatment regimen render a permanent cure highly...

  • Finding a cure for HIV: will it ever be achievable? Lewin, Sharon R.; Evans, Vanessa A.; Elliott, Julian H.; Spire, Bruno; Chomont, Nicolas // Journal of the International AIDS Society;2011, Vol. 14 Issue 1, p1 

    Combination antiretroviral therapy (cART) has led to a major reduction in HIV-related mortality and morbidity. However, HIV still cannot be cured. With the absence of an effective prophylactic or therapeutic vaccine, increasing numbers of infected people, emerging new toxicities secondary to...

  • Recent Achievements in Understanding Immune Recovery of Children Treated with HAART. Muñoz-Fernández, Ma Ángeles; Correa-Rocha, Rafael // Current Pediatric Reviews;2011, Vol. 7 Issue 3, p188 

    The natural course of HIV infection causes a severe depletion of CD4+ T cells, phenotypic alterations of T-cell subsets and a decline in thymic function, which in turn produces a progressive impairment of the immune function. HIV infected children present some distinct features when compared to...

  • Immune reconstitution inflammatory syndrome: the trouble with immunity when you had none. Barber, Daniel L.; Andrade, Bruno B.; Sereti, Irini; Sher, Alan // Nature Reviews Microbiology;Feb2012, Vol. 10 Issue 2, p150 

    Some individuals who are infected with HIV rapidly deteriorate shortly after starting antiretroviral therapy, despite effective viral suppression. This reaction, referred to as immune reconstitution inflammatory syndrome (IRIS), is characterized by tissue-destructive inflammation and arises as...

  • Effect of HIV-1 Subtype on Virologic and Immunologic Response to Starting Highly Active Antiretroviral Therapy. Geretti, Anna Maria; Harrison, Linda; Green, Hannah; Sabin, Caroline; Hill, Teresa; Fearnhill, Esther; Pillay, Deenan; Dunn, David // Clinical Infectious Diseases;5/1/2009, Vol. 48 Issue 9, p1296 

    Background. It has been proposed that subtype-related human immunodeficiency virus type 1 (HIV-1) variability may influence virologic and immunologic responses to highly active antiretroviral therapy (HAART). Studies to date, however, have described treatment outcomes predominantly in persons...

  • Intestinal barrier dysfunction in HIV infection: pathophysiology, clinical implications and potential therapies. Assimakopoulos, S.; Dimitropoulou, D.; Marangos, M.; Gogos, C. // Infection;Dec2014, Vol. 42 Issue 6, p951 

    Introduction: Current pathogenetic aspects on HIV infection highlight the importance of a chronic immune activation ultimately leading to T lymphocyte homeostasis disruption and immune deregulation associated with disease manifestations and progression. It is widely accepted that this continuous...

  • Lack of Mucosal Immune Reconstitution during Prolonged Treatment of Acute and Early HIV-1 Infection. Mehandru, Saurabh; Poles, Michael A.; Tenner-Racz, Klara; Jean-Pierre, Patrick; Manuelli, Victoria; Lopez, Peter; Shet, Anita; Low, Andrea; Mohri, Hiroshi; Boden, Daniel; Racz, Paul; Markowitz, Martin // PLoS Medicine;Dec2006, Vol. 3 Issue 12, p2335 

    Background During acute and early HIV-1 infection (AEI), up to 60% of CD4+ T cells in the lamina propria of the lower gastrointestinal (GI) tract are lost as early as 2-4 wk after infection. Reconstitution in the peripheral blood during therapy with highly active antiretroviral therapy (HAART)...

  • Unintegrated HIV-1 provides an inducible and functional reservoir in untreated and highly active antiretroviral therapy-treated patients. Petitjean, Gaël; Al Tabaa, Yassine; Tuaillon, Edouard; Mettling, Clement; Baillat, Vincent; Reynes, Jacques; Segondy, Michel; Vendrell, Jean Pierre // Retrovirology;2007, Vol. 4, p60 

    Background: The presence of HIV-1 preintegration reservoir was assessed in an in vitro experimental model of latent HIV-1 infection, and in patients treated or not with highly active antiretroviral therapy (HAART). Results: In resting CD4+ T lymphocytes latently infected in vitro with HIV-1, we...

  • Expanded Cytotoxic T-cell Lymphocytes Target the Latent HIV Reservoir. Sung, Julia A.; Lam, Sharon; Garrido, Carolina; Archin, Nancie; Rooney, Cliona M.; Bollard, Catherine M.; Margolis, David M. // Journal of Infectious Diseases;7/15/2015, Vol. 212 Issue 2, p258 

    Enhanced human immunodeficiency virus (HIV)-specific immunity may be required for HIV eradication. Administration of autologous, ex vivo expanded, virus-specific, cytotoxic T-lymphocytes derived from HIV-infected patients on suppressive antiretroviral therapy (HXTCs) are a powerful tool for...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics